JCCT

Lenexa, United States Founded: 2005 • Age: 21 yrs
CRO focused on early end stage clinical trial services
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 2 Services tracked
Competitors 8 Brand Intelligence

About JCCT

JCCT is a company based in Lenexa (United States) founded in 2005 by Casey Johnson, Mazen Zari, and Nathan Arthur. JCCT offers products and services including Clinical Trial Services and Vaccine Trials. JCCT operates in a competitive market with competitors including Medpace, Lambda Therapeutic, Dhiti Life Sciences, Diacrin and Ascada Research, among others.

  • Headquarter Lenexa, United States
  • Founders Casey Johnson, Mazen Zari, Nathan Arthur
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of JCCT

JCCT offers a comprehensive portfolio of products and services, including Clinical Trial Services and Vaccine Trials.

Product name locked
Category locked
Primary

Conducts studies for new medical treatments and participant compensation.

Product name locked
Category locked
Locked

Tests vaccines for diseases like norovirus and influenza.

People of JCCT

Headcount
Employee Profiles 1
Board Members and Advisors 2
Employee Profiles
People
Daniel White
CEO

Unlock access to complete

Board Members and Advisors
people
Nathan Arthur
Co-Founder and Co-Chairman
people
Mazen Zari
Co-Founder and Co-Chairman

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of JCCT

Investors in JCCT

JCCT has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include FFL Partners.

All
Venture Fund
Investor Description Founded Year Domain Location
Lower middle market investments are targeted by FFL Partners.
Locked Locked Locked
Premium access

Investor details for JCCT

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by JCCT

Investments
Premium access

Investment portfolio details for JCCT

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - JCCT

Premium access

Detailed financials for JCCT

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Jcct Comparisons

JCCT Primary company
Description
CRO focused on early & end stage clinical trial services
Location
Lenexa, United States
Founded Year
2005
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for JCCT

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of JCCT

JCCT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medpace, Lambda Therapeutic, Dhiti Life Sciences, Diacrin and Ascada Research, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
A range of clinical research services is offered by Medpace.
Locked Locked Locked
CRO with operations in India, US, Poland, Canada and UK. Winner of Frost & Sullivan 'CRO of the Year' - 2010
Locked Locked Locked
Biotechnology company offering in vitro diagnostic products for healthcare sector
Locked Locked Locked
Educational programs are provided by Diacrin since 1989.
Locked Locked Locked
Performs clinical research trials to evaluate investigational drugs and devices.
Premium access

Detailed competitors of JCCT

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Jcct

Premium access

Complete news archive for JCCT

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about JCCT

JCCT was founded in 2005 and raised its 1st funding round 18 years after it was founded.

JCCT is headquartered in Lenexa, United States. It is registered at Lenexa, Kansas, United States.

Mazen Zari is the current CEO of JCCT. They have also founded this company.

JCCT, established in 2005, excels in providing healthcare solutions, biopharma outsourcing, cro, clinical development, and full service. CRO focused on early end stage clinical trial services. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

JCCT's top competitors include Medpace, Lambda Therapeutic and Dhiti Life Sciences.

JCCT offers Clinical Trial Services and Vaccine Trials.

JCCT has 1 investor. Key investors include FFL Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available